Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombocytopenia: communication from the SSC of the ISTH.

Literature DB >> 25714467

Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombocytopenia: communication from the SSC of the ISTH.

T Bakchoul¹, J Fuhrmann, B H Chong, D Bougie, R Aster.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2015 PMID： 25714467 PMCID： PMC4424079 DOI： 10.1111/jth.12879

Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824

× No keyword cloud information.

9 in total

1. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.

Authors: Tamam Bakchoul; Sebastian Kubiak; Annika Krautwurst; Monika Roderfeld; Hans C Siebert; Gregor Bein; Ulrich J Sachs; Sentot Santoso
Journal: Transfusion Date: 2011-05-12 Impact factor: 3.157

2. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents.

Authors: Brian Boylan; Michael C Berndt; Mark L Kahn; Peter J Newman
Journal: Blood Date: 2006-03-28 Impact factor: 22.113

3. Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia.

Authors: Daniel W Bougie; Dhirendra Nayak; Brian Boylan; Peter J Newman; Richard H Aster
Journal: Blood Date: 2010-06-29 Impact factor: 22.113

4. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.

Authors: L D Shultz; P A Schweitzer; S W Christianson; B Gott; I B Schweitzer; B Tennent; S McKenna; L Mobraaten; T V Rajan; D L Greiner
Journal: J Immunol Date: 1995-01-01 Impact factor: 5.422

5. Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.

Authors: Julie A Peterson; Adam Kanack; Dhirendra Nayak; Daniel W Bougie; Janice G McFarland; Brian R Curtis; Richard H Aster
Journal: Transfusion Date: 2012-09-25 Impact factor: 3.157

6. Glycosylation of autoantibodies: insights into the mechanisms of immune thrombocytopenia.

Authors: Tamam Bakchoul; Kathrin Walek; Annika Krautwurst; Mathias Rummel; Gregor Bein; Sentot Santoso; Ulrich J Sachs
Journal: Thromb Haemost Date: 2013-09-26 Impact factor: 5.249

7. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.

Authors: Tamam Bakchoul; Andreas Greinacher; Ulrich J Sachs; Annika Krautwurst; Harald Renz; Habi Harb; Gregor Bein; Peter J Newman; Sentot Santoso
Journal: Blood Date: 2013-05-03 Impact factor: 22.113

Review 8. Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders.

Authors: P J Newman; R Aster; B Boylan
Journal: J Thromb Haemost Date: 2007-07 Impact factor: 5.824

9. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.

Authors: Tamam Bakchoul; Brian Boylan; Ulrich J H Sachs; Gregor Bein; Changgeng Ruan; Sentot Santoso; Peter J Newman
Journal: Transfusion Date: 2008-11-04 Impact factor: 3.157